FutureChem Co Ltd
KOSDAQ:220100
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7 800
30 900
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
FutureChem Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | KR |
Market Cap | 339.2B KRW |
Net Margin |
-58%
|
Country | US |
Market Cap | 1.3T USD |
Net Margin |
9%
|
Country | US |
Market Cap | 196.3B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 170.3B USD |
Net Margin |
18%
|
Country | KR |
Market Cap | 66.5T KRW |
Net Margin |
24%
|
Country | CH |
Market Cap | 37.6B CHF |
Net Margin |
9%
|
Country | US |
Market Cap | 38.5B USD |
Net Margin |
22%
|
Country | US |
Market Cap | 36.7B USD |
Net Margin |
9%
|
Country | US |
Market Cap | 26.4B USD |
Net Margin |
21%
|
Country | US |
Market Cap | 23B USD |
Net Margin |
17%
|
Country | US |
Market Cap | 22.3B USD |
Net Margin |
-36%
|
FutureChem Co Ltd
Glance View
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on FutureChem Co Ltd's most recent financial statements, the company has Net Margin of -58.5%.